Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy.
The PRIMAvera clinical trial included 38 patients with geographic atrophy who underwent implantation of the Prima retinal system. Results showed a “meaningful” improvement in visual acuity, according to a press release.
The system includes a photovoltaic implant that is implanted under the retina, a pair of glasses with a camera and projection system, and a pocket processor that clarifies and magnifies